Invention patent RU 2653125 C1. Date of registration: 23.05.2017 · 2017
Polymeric sorbent, method for its production and use.
No abstract available. Use the links below to access the full publication.
More publications
- Eferon LPS NEO hemoadsorption in pediatric sepsis patients: a multicenter controlled studyESICM LIVES 2025. ICMx 13 (Suppl 1), 109 (2025). · 2025
- Multimodal LPS-selective hemoadsorption combined with hemodiafiltration in the intensive care of gram-negative sepsis: a multicenter observational study.General Reanimatology. 2025;21(6):4–12. · 2025
- Hemoperfusion with Efferon LPS NEO device reverts multiple organ failure, decreases IL-6 and TNF levels and systemic immune inflammation in children with sepsisCritical Care 2024, 28(Suppl 1):P220 · 2024
- Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trialShock. 2023 Jun 1;59(6):846-854 · 2023
- Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsisIntensive Care Medicine Experimental 2022, 10(2): 000710 · 2022
- Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observationTherapeutic archive. 2021; 93 (7): 811-817 · 2021
- Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shockWorld Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50. · 2021
- Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)General resuscitation. 2020; 16 (4): 14-20. · 2020
- Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shockGeneral resuscitation. 2020; 16 (6): 31-53. · 2020
- Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)General resuscitation. 2018; 14 (6): 51-60. · 2018
- Method for determination of bacterial endotoxin in biological fluids.Invention patent RU 2691413 C1. Date of registration: 26.12.2017 · 2017
- Methods for the determination of bacterial endotoxin in critical care medicine (review).General resuscitation. 2017; 13 (5): 109-120. · 2017
- Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)General resuscitation. 2016; 12 (6): 82-107. · 2016